【康希诺：股票交易异常波动，市场关注mRNA技术发展】康希诺公告，公司股票于2026年8月19日、8月20日及8月21日连续3个交易日内日收盘价格涨幅偏离值累计超过30%。公司生产经营正常，市场环境、行业政策未发生重大调整；近期市场关注mRNA技术，公司正推进相关疫苗、治疗性生物制品及递送系统开发，相关研发目前均处于早期阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.